首页> 外国专利> HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4.

HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4.

机译:人抗人血管生成素样蛋白的抗体4。

摘要

A fully human antibody or antigen -binding fragment of a human antibody that specifically binds and inhibits human angiopoietin - like protein 4 (hANGPTL4) is provided. The human anti- hANGPTL4 antibodies are useful in treating diseases or disorders associated with ANGPTL4, such as hyperlipidemia, hyperlipoproteinemia and dyslipidemia, including hypertriglyceridemia, hypercholesterolemia, chylomicronemia, and so forth. Furthermore, the anti -hANGPTL4 antibodies can be administered to a subject in need thereof to prevent or treat diseases or disorders, for which abnormal lipid metabolism is a risk factor. Such diseases or disorders include cardiovascular diseases, such as atherosclerosis and coronary artery diseases; acute pancreatitis; nonalcoholic steatohepatitis (NASH); diabetes; obesity.
机译:提供了特异性结合并抑制人血管生成素样蛋白4(hANGPTL4)的完全人抗体或人抗体的抗原结合片段。人抗hANGPTL4抗体可用于治疗与ANGPTL4相关的疾病或病症,例如高脂血症,高脂蛋白血症和血脂异常,包括高甘油三酸酯血症,高胆固醇血症,乳糜微粒血症等。此外,可以将抗-hANGPTL4抗体施用于需要其的受试者以预防或治疗异常脂类代谢是危险因素的疾病或病症。这些疾病或病症包括心血管疾病,例如动脉粥样硬化和冠状动脉疾病;急性胰腺炎;非酒精性脂肪性肝炎(NASH);糖尿病;肥胖。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号